Visión generalGráficoNoticiasTraderScreen

Soc. Generale Knock-Out RWE/  DE000CL7G188  /

EUWAX
31/05/2024  17:34:08 Diferencia-0.01 Bid22:00:34 Ask22:00:34 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
1.24EUR -0.80% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 RWE AG INH O.N. 22.4902 - 31/12/2078 Call
TeleTrader 17:37 Hezbollah rockets strike Israeli base in northern Israel
TeleTrader 17:02 Israel's Lapid slams government over post-war plan
Newsfile Corp 17:00 WATCH by Aisles: A Revolutionary AI System for Public Safety
TeleTrader 16:16 Belgium condemns Israel's bid to label UNRWA as terrorist
GlobeNewswire 16:00 SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstr...
GlobeNewswire 16:00 Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...
GlobeNewswire 16:00 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
TeleTrader 15:23 Macron backs Biden's ceasefire proposal for Gaza
GlobeNewswire 15:14 Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
GlobeNewswire 15:00 ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Ther...
GlobeNewswire 15:00 Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monothera...
TeleTrader 14:35 ANC loses 30-year majority in S. Africa
GlobeNewswire 14:15 FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with ...
GlobeNewswire 14:15 Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
GlobeNewswire 14:05 Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
GlobeNewswire 14:00 Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (NYSE: WOW) and Encourages...
GlobeNewswire 14:00 Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonst...
GlobeNewswire 14:00 Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin)...
GlobeNewswire 14:00 OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
GlobeNewswire 14:00 Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at...
GlobeNewswire 14:00 CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
GlobeNewswire 14:00 Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confi...
GlobeNewswire 13:55 ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors...
TeleTrader 13:41 Netanyahu: Ceasefire tied to Hamas dismantling
GlobeNewswire 13:00 Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...